1. Home
  2. OBK vs FTRE Comparison

OBK vs FTRE Comparison

Compare OBK & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Origin Bancorp Inc.

OBK

Origin Bancorp Inc.

HOLD

Current Price

$50.79

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$17.98

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBK
FTRE
Founded
1912
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
OBK
FTRE
Price
$50.79
$17.98
Analyst Decision
Strong Buy
Buy
Analyst Count
6
9
Target Price
$46.67
$14.06
AVG Volume (30 Days)
137.2K
1.4M
Earning Date
04-22-2026
05-05-2026
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
0.89
N/A
Revenue
N/A
$2,723,400,000.00
Revenue This Year
$26.43
N/A
Revenue Next Year
$5.79
$3.09
P/E Ratio
$57.22
N/A
Revenue Growth
N/A
1.00
52 Week Low
$32.13
$4.46
52 Week High
$52.90
$18.67

Technical Indicators

Market Signals
Indicator
OBK
FTRE
Relative Strength Index (RSI) 54.99 62.82
Support Level $48.10 $15.40
Resistance Level $52.90 $18.13
Average True Range (ATR) 1.04 0.90
MACD -0.18 -0.05
Stochastic Oscillator 26.99 80.00

Price Performance

Historical Comparison
OBK
FTRE

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: